gullapalli

In the Phase III STRATUM trial, 80% of patients succeeded in the treatment by week eight using ZORYVE foam. Credit: Arcutis Biotherapeutics, Inc./GlobeNewswire. Arcutis Biotherapeutics‘ subsidiary, Arcutis Canada, has received Health Canada’s approval for ZORYVE (roflumilast) topical foam 0.3%, to […]

The agreement is intended for the development and manufacture of a cell-based therapy for a diabetic foot ulcer clinical trial. Credit: Olga Apanasenko/Shutterstock. FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies

VYLOY is used in conjunction with chemotherapy for the treatment of advanced gastric and gastroesophageal junction cancer. Credit: Emily frost/Shutterstock.com. Astellas Pharma has gained approval from the US Food and Drug Administration (FDA) for VYLOY (zolbetuximab-clzb), in conjunction with chemotherapy,

Results from Phase III clinical trials have demonstrated that BRENZAVVY significantly lowers haemoglobin A1c and fasting blood sugar levels over 24 weeks. Credit: Dragana Gordic/Shutterstock. TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin), a type 2

The new entity focuses on the discovery, design and development of RLTs. Credit: PeopleImages.com – Yuri A/Shutterstock. Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation radioligand therapies (RLTs) for rare cancers.

Parkinson’s disease is a chronic neurological disorder marked by symptoms such as tremors and muscle rigidity. Credit: chainarong06/Shutterstock. The US Food and Drug Administration (FDA) has approved AbbVie‘s VYALEV (foscarbidopa and foslevodopa) to treat motor fluctuations in adults with advanced

The development agreement will see Fresenius Kabi’s cell therapy processing technologies integrated into Cellular Origins’ robotic platform. Credit: Kotin/Shutterstock. Fresenius Kabi and Cellular Origins have announced a partnership to advance the field of cell and gene therapy (CGT) by automating

Rett syndrome is a rare neurodevelopmental disorder that predominantly affects females. Credit: SewCreamStudio/Shutterstock. Acadia Pharmaceuticals has received marketing authorisation from Health Canada for DAYBUE (trofinetide) to treat Rett syndrome in adult and paediatric patients aged two years and above. Rett

The partnership is set to capitalise on Viatris’ extensive global reach and expertise in the cardiovascular sector. Credit: Jo Panuwat D/Shutterstock. Lexicon Pharmaceuticals has entered a licensing agreement with Viatris, granting the latter exclusive rights to commercialise sotagliflozin in all

The collaboration intends to strengthen both companies’ expertise to develop new radiotherapeutic solutions for cancer. Credit: Frame Stock Footage/Shutterstock. Radiopharm Theranostics (RAD) and AtomVie Global Radiopharma have announced a partnership for the development and manufacturing of 177Lu-BetaBart radioantibody to treat